Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
dihydroergotamine (D.H.E. 45) (2021)
dihydroergotamine (D.H.E. 45) (2 trials)
levodopa (larodopa) (1 trial)
olanzapine (zyprexa) (2 trials)
Headache (Phase 3)
Migraine Disorders (Phase 3)
Parkinson Disease (Phase 2)
Psychomotor Agitation (Phase 1)
Trials (5 total)
Trial APIs (3 total)